News > Meningococcal Vaccines Market Size Expected to Reach $4.2 Billion by 2026

Meningococcal Vaccines Market Size Expected to Reach $4.2 Billion by 2026

Meningococcal Vaccines Market size is expected to reach $4.2 billion by 2026, growing at a CAGR of 10.8% during the forecast period 2021-2026. Meningococcal vaccines are polysaccharide vaccines that are used to prevent diseases caused by meningococcus, which is a Gram-negative bacterium that can cause meningitis and other forms of meningococcal disease such as meningococcemia.

The meningococcal disease results in infection of the lining of the brain and spinal cord and also has the potential to cause large epidemics.